Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1026 | 1012 | 1050 | 1004 | 1039 | 1137 |
Fund Return | 2.61% | 1.23% | 5.02% | 0.14% | 0.76% | 1.29% |
Place in category | 452 | 801 | 1647 | 609 | 1061 | 427 |
% in Category | 21 | 36 | 67 | 32 | 58 | 46 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Adamant Medtech B EUR | 1.54B | 6.99 | 3.61 | 12.61 | ||
Adamant Medtech I EUR | 1.54B | 7.30 | 4.33 | 13.41 | ||
Adamant Medtech T EUR | 1.54B | 7.17 | 4.02 | 13.06 | ||
Bellevues Lux BB Adamant Medtech HB | 1.54B | 5.04 | -2.34 | 8.66 | ||
LU1477743386 | 433.22M | 2.80 | -1.84 | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
M&G Optimal Income Fund A EUR Inc | 9.38B | -2.67 | -2.06 | 1.06 | ||
M&G Optimal Income Fund A EUR Acc | 9.38B | -2.67 | -2.06 | 1.04 | ||
PI Multi Asset Global Opportunities | 5.33B | 1.99 | -0.25 | 2.68 | ||
Pictet Multi Asset Global R | 5.33B | 1.63 | -1.29 | 1.48 | ||
Pictet-Multi Asset Global Opport P | 5.33B | 1.83 | -0.72 | 2.23 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
GS Liquid Euro-C Cap EUR | LU0245567192 | 15.10 | - | - | |
Amundi Euro Liquidity-Rated SRI I | FR0007038138 | 14.94 | - | - | |
LO Funds Short-Term Money Market EUR IA | LU1577896191 | 14.11 | - | - | |
Pictet-Short-Term Money Market EUR I | LU0128494944 | 14.09 | 143.666 | +0.01% | |
Parvest Money Market Euro I Capitalisation | LU0102012688 | 14.09 | 74.491 | +0.03% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Buy | Buy |
Technical Indicators | BUY | Strong Buy | Strong Buy |
Summary | Buy | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review